Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:51:58 UTC |
---|
HMDB ID | HMDB0015399 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Arformoterol |
---|
Description | Arformoterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Arformoterol inhalation is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. The use of arformoterol is pending revision due to safety concerns in regards to an increased risk of severe exacerbation of asthma symptoms, leading to hospitalization as well as death in some patients using long acting beta agonists for the treatment of asthma. |
---|
Structure | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1 InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1 |
---|
Synonyms | Value | Source |
---|
(-)-Formoterol | ChEBI | (R,R)-Formoterol | ChEBI | 3-Formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate | HMDB | Oxis | HMDB | Formoterol fumarate | HMDB | BD 40a | HMDB | Foradil | HMDB | Formoterol, ((r*,r*)-(+-))-isomer | HMDB | Eformoterol | HMDB | Formoterol | HMDB | Formoterol fumarate, ((r*,r*)-(+-))-isomer | HMDB |
|
---|
Chemical Formula | C19H24N2O4 |
---|
Average Molecular Weight | 344.4049 |
---|
Monoisotopic Molecular Weight | 344.173607266 |
---|
IUPAC Name | N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide |
---|
Traditional Name | arformoterol |
---|
CAS Registry Number | 67346-49-0 |
---|
SMILES | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1 |
---|
InChI Key | BPZSYCZIITTYBL-YJYMSZOUSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenethylamines |
---|
Direct Parent | Amphetamines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Amphetamine or derivatives
- Phenylpropane
- Anilide
- Phenoxy compound
- Anisole
- Phenol ether
- N-arylamide
- Methoxybenzene
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Aralkylamine
- Secondary carboxylic acid amide
- Secondary alcohol
- Amino acid or derivatives
- 1,2-aminoalcohol
- Carboxamide group
- Secondary amine
- Carboxylic acid derivative
- Secondary aliphatic amine
- Ether
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Carbonyl group
- Alcohol
- Organic nitrogen compound
- Organopnictogen compound
- Aromatic alcohol
- Organic oxide
- Amine
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | - N-[2-hydroxy-5-(1-hydroxy-2-\{[1-(4-methoxyphenyl)propan-2-yl]amino\}ethyl)phenyl]formamide (CHEBI:408174 )
|
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.042 g/L | Not Available | LogP | 2.2 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Arformoterol,1TMS,isomer #1 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O)C(NC=O)=C2)C=C1 | 3238.9 | Semi standard non polar | 33892256 | Arformoterol,1TMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)C=C1 | 3270.5 | Semi standard non polar | 33892256 | Arformoterol,1TMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3273.9 | Semi standard non polar | 33892256 | Arformoterol,1TMS,isomer #4 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 3021.6 | Semi standard non polar | 33892256 | Arformoterol,2TMS,isomer #1 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)C=C1 | 3194.4 | Semi standard non polar | 33892256 | Arformoterol,2TMS,isomer #2 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3213.8 | Semi standard non polar | 33892256 | Arformoterol,2TMS,isomer #3 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 2920.9 | Semi standard non polar | 33892256 | Arformoterol,2TMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3264.5 | Semi standard non polar | 33892256 | Arformoterol,2TMS,isomer #5 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 3038.4 | Semi standard non polar | 33892256 | Arformoterol,2TMS,isomer #6 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3013.4 | Semi standard non polar | 33892256 | Arformoterol,3TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3246.8 | Semi standard non polar | 33892256 | Arformoterol,3TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 2891.4 | Standard non polar | 33892256 | Arformoterol,3TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3639.8 | Standard polar | 33892256 | Arformoterol,3TMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 2978.4 | Semi standard non polar | 33892256 | Arformoterol,3TMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 2660.7 | Standard non polar | 33892256 | Arformoterol,3TMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 3452.6 | Standard polar | 33892256 | Arformoterol,3TMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3002.4 | Semi standard non polar | 33892256 | Arformoterol,3TMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 2814.0 | Standard non polar | 33892256 | Arformoterol,3TMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3615.3 | Standard polar | 33892256 | Arformoterol,3TMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3050.6 | Semi standard non polar | 33892256 | Arformoterol,3TMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 2878.4 | Standard non polar | 33892256 | Arformoterol,3TMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3654.3 | Standard polar | 33892256 | Arformoterol,4TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3085.9 | Semi standard non polar | 33892256 | Arformoterol,4TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 2735.0 | Standard non polar | 33892256 | Arformoterol,4TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3382.4 | Standard polar | 33892256 | Arformoterol,1TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(NC=O)=C2)C=C1 | 3498.6 | Semi standard non polar | 33892256 | Arformoterol,1TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)C=C1 | 3530.2 | Semi standard non polar | 33892256 | Arformoterol,1TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3546.0 | Semi standard non polar | 33892256 | Arformoterol,1TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3292.6 | Semi standard non polar | 33892256 | Arformoterol,2TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)C=C1 | 3679.4 | Semi standard non polar | 33892256 | Arformoterol,2TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3753.9 | Semi standard non polar | 33892256 | Arformoterol,2TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3415.4 | Semi standard non polar | 33892256 | Arformoterol,2TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3773.3 | Semi standard non polar | 33892256 | Arformoterol,2TBDMS,isomer #5 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3525.0 | Semi standard non polar | 33892256 | Arformoterol,2TBDMS,isomer #6 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3536.9 | Semi standard non polar | 33892256 | Arformoterol,3TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3964.3 | Semi standard non polar | 33892256 | Arformoterol,3TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3498.4 | Standard non polar | 33892256 | Arformoterol,3TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3811.3 | Standard polar | 33892256 | Arformoterol,3TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3646.0 | Semi standard non polar | 33892256 | Arformoterol,3TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3155.3 | Standard non polar | 33892256 | Arformoterol,3TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3683.5 | Standard polar | 33892256 | Arformoterol,3TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3738.7 | Semi standard non polar | 33892256 | Arformoterol,3TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3331.6 | Standard non polar | 33892256 | Arformoterol,3TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3805.7 | Standard polar | 33892256 | Arformoterol,3TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3783.2 | Semi standard non polar | 33892256 | Arformoterol,3TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3343.3 | Standard non polar | 33892256 | Arformoterol,3TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3862.2 | Standard polar | 33892256 | Arformoterol,4TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3976.1 | Semi standard non polar | 33892256 | Arformoterol,4TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3359.3 | Standard non polar | 33892256 | Arformoterol,4TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3677.7 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Arformoterol GC-MS (Non-derivatized) - 70eV, Positive | splash10-00or-2902000000-10d83ebb89a446028d15 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Arformoterol GC-MS (2 TMS) - 70eV, Positive | splash10-0079-1290400000-a5f812e6f46ebe2c4573 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Arformoterol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 10V, Positive-QTOF | splash10-00mk-0119000000-960431f56a40133b8573 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 20V, Positive-QTOF | splash10-002b-0937000000-93717c858174f9fabf66 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 40V, Positive-QTOF | splash10-0002-0900000000-d7f4b9eb1c7882357173 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 10V, Negative-QTOF | splash10-004l-4209000000-f9910c5b8f497127e7ca | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 20V, Negative-QTOF | splash10-03fu-3619000000-7dd84dcd46e229246839 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 40V, Negative-QTOF | splash10-002f-9400000000-58f5ee81bd6c210528d7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 10V, Positive-QTOF | splash10-002b-0059000000-c0053d7ff48e5b7bf21e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 20V, Positive-QTOF | splash10-05bb-0797000000-ccdaa7ef72717418b1b7 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 40V, Positive-QTOF | splash10-022c-1911000000-a90ad156589941d202e7 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 10V, Negative-QTOF | splash10-0007-0039000000-690e9c11e66c66a1a005 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 20V, Negative-QTOF | splash10-0007-3795000000-80c4a6628c8460481d11 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 40V, Negative-QTOF | splash10-0017-5391000000-9e5db81cdfc6dd49e8ea | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01274 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01274 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01274 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 2340731 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Arformoterol |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 3083544 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 408174 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Cazzola M, Matera MG, Lotvall J: Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs. 2005 Jul;14(7):775-83. [PubMed:16022567 ]
- Kharidia J, Fogarty CM, Laforce CF, Maier G, Hsu R, Dunnington KM, Curry L, Baumgartner RA, Hanrahan JP: A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2008 Aug;21(4):657-62. doi: 10.1016/j.pupt.2008.03.003. Epub 2008 Apr 7. [PubMed:18501650 ]
- Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP: Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clin Ther. 2007 Feb;29(2):261-78. [PubMed:17472819 ]
- Donohue JF, Hanania NA, Sciarappa KA, Goodwin E, Grogan DR, Baumgartner RA, Hanrahan JP: Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. Ther Adv Respir Dis. 2008 Apr;2(2):37-48. doi: 10.1177/1753465808089455. [PubMed:19124357 ]
- Panettieri RA Jr, MacIntyre N, Sims M, Kerwin E, Fogarty C, Noonan M, Claus R, Andrews WT: Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study. Clin Ther. 2009 Aug;31(8):1716-23. doi: 10.1016/j.clinthera.2009.08.012. [PubMed:19808130 ]
- Hanania NA, Donohue JF, Nelson H, Sciarappa K, Goodwin E, Baumgartner RA, Hanrahan JP: The safety and efficacy of arformoterol and formoterol in COPD. COPD. 2010 Feb;7(1):17-31. doi: 10.3109/15412550903499498. [PubMed:20214460 ]
|
---|